Portfolio Holdings Detail for ISIN IE00BDZVHG35
Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /var/www/liquidata/show_ticker_holding_ETFs.php on line 77
Stock Name / Fund iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Issuer Blackrock

ETF Ticker BTEE(USD) LSE
ETF Ticker BTEE.L(GBP) LSE

Holdings detail for IMCR

Stock Name	Immunocore Holdings Ltd
Ticker	IMCR(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US45258D1054
LEI	213800IUE3DFS84BVN18

Show aggregate IMCR holdings

News associated with IMCR

Analysts Set Immunocore Holdings PLC Sponsored ADR (NASDAQ:IMCR) PT at $56.89: Shares of Immunocore Holdings PLC Sponsored ADR (NASDAQ:IMCR – Get Free Report) have earned a consensus recommendation of “Hold” from the eleven analysts that are presently covering the firm, MarketBeat reports. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and six have given a buy rating […] - 2025-09-15 02:30:24
Immunocore (NASDAQ:IMCR) Coverage Initiated at Jefferies Financial Group: Equities research analysts at Jefferies Financial Group initiated coverage on shares of Immunocore (NASDAQ:IMCR – Get Free Report) in a research report issued to clients and investors on Monday. The firm set a “buy” rating and a $48.00 price target on the stock. Jefferies Financial Group’s price target would suggest a potential upside of 47.19% […] - 2025-08-27 02:08:52
Immunocore Holdings PLC Sponsored ADR (NASDAQ:IMCR) Given Consensus Rating of “Moderate Buy” by Analysts: Shares of Immunocore Holdings PLC Sponsored ADR (NASDAQ:IMCR – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the ten brokerages that are presently covering the stock, Marketbeat reports. One research analyst has rated the stock with a sell rating, three have given a hold rating and six have issued a […] - 2025-08-18 05:10:58
XTX Topco Ltd Decreases Stock Position in Immunocore Holdings PLC Sponsored ADR (NASDAQ:IMCR): XTX Topco Ltd lessened its position in Immunocore Holdings PLC Sponsored ADR (NASDAQ:IMCR – Free Report) by 3.7% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 18,192 shares of the company’s stock after selling 704 shares during the quarter. […] - 2025-08-07 05:00:52
Oppenheimer Asset Management Inc. Takes $225,000 Position in Immunocore Holdings PLC Sponsored ADR (NASDAQ:IMCR): Oppenheimer Asset Management Inc. bought a new position in shares of Immunocore Holdings PLC Sponsored ADR (NASDAQ:IMCR – Free Report) in the 1st quarter, Holdings Channel.com reports. The institutional investor bought 7,574 shares of the company’s stock, valued at approximately $225,000. Several other hedge funds and other institutional investors have also modified their holdings of […] - 2025-07-01 04:50:55
GAMMA Investing LLC Increases Stock Position in Immunocore Holdings plc (NASDAQ:IMCR): GAMMA Investing LLC increased its position in shares of Immunocore Holdings plc (NASDAQ:IMCR – Free Report) by 3,318.1% during the first quarter, HoldingsChannel.com reports. The institutional investor owned 19,107 shares of the company’s stock after buying an additional 18,548 shares during the quarter. GAMMA Investing LLC’s holdings in Immunocore were worth $5,670,000 as of its […] - 2025-06-10 04:38:58
HC Wainwright Reiterates “Buy” Rating for Immunocore (NASDAQ:IMCR): Immunocore (NASDAQ:IMCR – Get Free Report)‘s stock had its “buy” rating restated by stock analysts at HC Wainwright in a research note issued on Monday,Benzinga reports. They currently have a $100.00 price target on the stock. HC Wainwright’s price target indicates a potential upside of 158.80% from the stock’s previous close. A number of other […] - 2025-06-04 02:51:03
Immunocore Holdings plc (NASDAQ:IMCR) Shares Sold by Squarepoint Ops LLC: Squarepoint Ops LLC lowered its stake in Immunocore Holdings plc (NASDAQ:IMCR – Free Report) by 2.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 69,954 shares of the company’s stock after selling 2,114 shares during the quarter. Squarepoint Ops LLC owned about […] - 2025-05-29 05:18:57
Deutsche Bank Aktiengesellschaft Initiates Coverage on Immunocore (NASDAQ:IMCR): Deutsche Bank Aktiengesellschaft assumed coverage on shares of Immunocore (NASDAQ:IMCR – Get Free Report) in a note issued to investors on Tuesday, MarketBeat reports. The brokerage set a “buy” rating and a $65.00 price target on the stock. Deutsche Bank Aktiengesellschaft’s target price indicates a potential upside of 106.41% from the company’s previous close. Other […] - 2025-05-29 02:31:00
Millennium Management LLC Cuts Stake in Immunocore Holdings plc (NASDAQ:IMCR): Millennium Management LLC reduced its stake in Immunocore Holdings plc (NASDAQ:IMCR – Free Report) by 15.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 573,362 shares of the company’s stock after selling 103,269 shares during the period. Millennium Management […] - 2025-05-22 05:01:00
BNP Paribas Financial Markets Makes New Investment in Immunocore Holdings plc (NASDAQ:IMCR): BNP Paribas Financial Markets bought a new position in Immunocore Holdings plc (NASDAQ:IMCR – Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 193,115 shares of the company’s stock, valued at approximately $5,697,000. BNP Paribas Financial Markets owned 0.39% of Immunocore as […] - 2025-05-14 06:10:56
Immunocore Holdings plc (NASDAQ:IMCR) Receives $58.13 Consensus PT from Brokerages: Shares of Immunocore Holdings plc (NASDAQ:IMCR – Get Free Report) have earned an average rating of “Moderate Buy” from the ten brokerages that are currently covering the stock, Marketbeat reports. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and six have assigned a buy rating to […] - 2025-05-13 02:44:54
Barclays PLC Buys 19,663 Shares of Immunocore Holdings plc (NASDAQ:IMCR): Barclays PLC increased its stake in Immunocore Holdings plc (NASDAQ:IMCR – Free Report) by 2,044.0% in the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 20,625 shares of the company’s stock after purchasing an additional 19,663 shares during the quarter. Barclays PLC’s holdings in Immunocore were […] - 2025-05-08 04:36:44
Marshall Wace LLP Lowers Stock Holdings in Immunocore Holdings plc (NASDAQ:IMCR): Marshall Wace LLP lessened its holdings in shares of Immunocore Holdings plc (NASDAQ:IMCR – Free Report) by 85.7% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 28,610 shares of the company’s stock after selling 170,833 shares during the quarter. Marshall Wace […] - 2025-05-01 05:43:01
Immunocore Holdings plc (NASDAQ:IMCR) Stake Boosted by Geode Capital Management LLC: Geode Capital Management LLC grew its stake in shares of Immunocore Holdings plc (NASDAQ:IMCR – Free Report) by 1.2% during the 4th quarter, HoldingsChannel reports. The fund owned 35,492 shares of the company’s stock after acquiring an additional 420 shares during the period. Geode Capital Management LLC’s holdings in Immunocore were worth $1,047,000 as of […] - 2025-05-01 04:32:55
Renaissance Technologies LLC Sells 179,630 Shares of Immunocore Holdings plc (NASDAQ:IMCR): Renaissance Technologies LLC decreased its position in shares of Immunocore Holdings plc (NASDAQ:IMCR – Free Report) by 65.0% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 96,570 shares of the company’s stock after selling 179,630 shares during the period. Renaissance Technologies LLC owned […] - 2025-04-25 05:17:01
Brokerages Set Immunocore Holdings plc (NASDAQ:IMCR) Price Target at $63.73: Immunocore Holdings plc (NASDAQ:IMCR – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the thirteen brokerages that are covering the stock, Marketbeat Ratings reports. One analyst has rated the stock with a sell recommendation, four have assigned a hold recommendation and eight have issued a buy recommendation on the company. […] - 2025-04-18 02:28:59
Immunocore Holdings plc (NASDAQ:IMCR) Shares Sold by Orion Portfolio Solutions LLC: Orion Portfolio Solutions LLC lessened its position in Immunocore Holdings plc (NASDAQ:IMCR – Free Report) by 37.1% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 13,017 shares of the company’s stock after selling 7,675 shares during the period. Orion Portfolio […] - 2025-04-09 05:02:51
Financial Contrast: Immunocore (NASDAQ:IMCR) vs. Creative Medical Technology (NASDAQ:CELZ): Creative Medical Technology (NASDAQ:CELZ – Get Free Report) and Immunocore (NASDAQ:IMCR – Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, dividends, risk, institutional ownership, valuation, profitability and analyst recommendations. Earnings and Valuation This table compares Creative […] - 2025-04-01 02:57:01
Immunocore Holdings plc (NASDAQ:IMCR) Receives Consensus Recommendation of “Moderate Buy” from Analysts: Shares of Immunocore Holdings plc (NASDAQ:IMCR – Get Free Report) have earned a consensus rating of “Moderate Buy” from the thirteen analysts that are presently covering the company, Marketbeat reports. One analyst has rated the stock with a sell recommendation, four have assigned a hold recommendation and eight have given a buy recommendation to the […] - 2025-03-26 04:56:59
Principal Financial Group Inc. Sells 43,461 Shares of Immunocore Holdings plc (NASDAQ:IMCR): Principal Financial Group Inc. reduced its position in shares of Immunocore Holdings plc (NASDAQ:IMCR – Free Report) by 8.0% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 502,857 shares of the company’s stock after selling 43,461 shares during the period. Principal Financial […] - 2025-02-27 07:06:54
Immunocore Holdings plc (NASDAQ:IMCR) Receives Average Rating of “Moderate Buy” from Analysts: Shares of Immunocore Holdings plc (NASDAQ:IMCR – Get Free Report) have received an average recommendation of “Moderate Buy” from the thirteen research firms that are currently covering the firm, MarketBeat.com reports. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and eight have assigned a buy rating […] - 2025-02-04 06:36:58

iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) IMCR holdings

Date	Number of IMCR Shares Held	Base Market Value of IMCR Shares	Local Market Value of IMCR Shares	Change in IMCR Shares Held	Change in IMCR Base Value	Current Price per IMCR Share Held	Previous Price per IMCR Share Held
2025-11-11 (Tuesday)	26,409	USD 929,597	USD 929,597	0	USD 5,282	USD 35.2	USD 35
2025-11-10 (Monday)	26,409	USD 924,315	USD 924,315	67	USD 41,858	USD 35	USD 33.5
2025-11-07 (Friday)	26,342	USD 882,457	USD 882,457	0	USD 50,182	USD 33.5	USD 31.595
2025-11-06 (Thursday)	26,342	USD 832,275	USD 832,275	68	USD 23,036	USD 31.595	USD 30.8
2025-11-05 (Wednesday)	26,274	USD 809,239	USD 809,239	0	USD -29,164	USD 30.8	USD 31.91
2025-11-04 (Tuesday)	26,274	USD 838,403	USD 838,403	68	USD -10,147	USD 31.91	USD 32.38
2025-11-03 (Monday)	26,206	USD 848,550	USD 848,550	0	USD -18,607	USD 32.38	USD 33.09
2025-10-31 (Friday)	26,206	USD 867,157	USD 867,157	0	USD 23,586	USD 33.09	USD 32.19
2025-10-30 (Thursday)	26,206	USD 843,571	USD 843,571	340	USD -6,127	USD 32.19	USD 32.85
2025-10-29 (Wednesday)	25,866	USD 849,698	USD 849,698	136	USD -18,690	USD 32.85	USD 33.75
2025-10-28 (Tuesday)	25,730	USD 868,388	USD 868,388	0	USD 7,462	USD 33.75	USD 33.46
2025-10-27 (Monday)	25,730	USD 860,926	USD 860,926	0	USD 9,134	USD 33.46	USD 33.105

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of IMCR by Blackrock for IE00BDZVHG35

Show aggregate share trades of IMCR

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-11-10 BUY 67 35.480 33.940 34.094 USD 2,284 31.62
2025-11-06 BUY 68 31.750 30.500 30.625 USD 2,083 31.61
2025-11-04 BUY 68 32.503 31.330 31.447 USD 2,138 31.61
2025-10-30 BUY 340 33.500 32.085 32.226 USD 10,957 31.60
2025-10-29 BUY 136 32.850 33.855 33.754 USD 4,591 31.59
2025-10-22 SELL -272 32.510 33.770 33.644 USD -9,151 31.55 Loss of -569 on sale
2025-10-20 BUY 136 33.940 33.990 33.985 USD 4,622 31.53
2025-10-17 BUY 339 33.560 34.220 34.154 USD 11,578 31.51
2025-10-15 BUY 536 34.390 34.510 34.498 USD 18,491 31.50
2025-10-03 BUY 455 34.210 35.500 35.371 USD 16,094 31.48
2025-10-02 BUY 65 35.290 37.000 36.829 USD 2,394 31.46
2025-09-30 BUY 130 36.330 36.720 36.681 USD 4,769 31.40
2025-09-26 BUY 130 34.020 35.003 34.905 USD 4,538 31.36
2025-09-25 BUY 130 34.080 34.340 34.314 USD 4,461 31.35
2025-09-18 BUY 68 33.415 34.415 34.315 USD 2,333 31.33
2025-09-17 BUY 204 33.415 34.470 34.365 USD 7,010 31.32
2025-07-17 SELL -134 36.210 36.360 36.345 USD -4,870 31.21 Loss of -689 on sale
2025-07-11 SELL -544 35.020 35.280 35.254 USD -19,178 31.10 Loss of -2,261 on sale
2025-07-02 BUY 3,740 32.750 33.950 33.830 USD 126,524 31.02
2025-06-25 BUY 136 32.010 32.350 32.316 USD 4,395 31.00
2025-06-13 BUY 765 34.680 36.010 35.877 USD 27,446 30.93
2025-06-11 BUY 130 35.560 37.100 36.946 USD 4,803 30.86
2025-06-10 BUY 130 35.930 37.560 37.397 USD 4,862 30.82
2025-06-04 SELL -65 37.700 39.330 39.167 USD -2,546 30.62 Loss of -556 on sale
2025-04-23 BUY 65 29.800 30.850 30.745 USD 1,998 30.45
2025-04-10 SELL -520 25.820 26.290 26.243 USD -13,646 30.72 Profit of 2,327 on sale
2025-04-08 SELL -65 24.530 27.670 27.356 USD -1,778 30.84 Profit of 227 on sale
2025-04-07 SELL -65 26.280 27.195 27.103 USD -1,762 30.90 Profit of 246 on sale
2025-04-04 SELL -325 27.260 28.555 28.426 USD -9,238 30.94 Profit of 816 on sale
2025-04-01 BUY 272 28.630 29.670 29.566 USD 8,042 30.98
2025-03-31 SELL -195 29.670 29.840 29.823 USD -5,815 31.00 Profit of 229 on sale
2025-03-21 BUY 884 29.810 30.970 30.854 USD 27,275 31.11
2025-03-14 SELL -1,008 28.800 29.840 29.736 USD -29,974 31.23 Profit of 1,511 on sale
2025-03-07 SELL -126 29.800 31.200 31.060 USD -3,914 31.41 Profit of 44 on sale
2025-03-04 SELL -63 29.250 29.570 29.538 USD -1,861 31.47 Profit of 122 on sale
2025-02-25 BUY 126 29.210 30.960 30.785 USD 3,879 31.64
2025-02-19 SELL -63 29.770 29.930 29.914 USD -1,885 31.77 Profit of 117 on sale
2025-02-13 BUY 186 29.740 30.050 30.019 USD 5,584 31.95
2025-02-12 BUY 62 29.560 29.785 29.762 USD 1,845 32.00
2025-02-11 BUY 248 28.205 30.120 29.929 USD 7,422 32.07
2024-12-30 SELL -1,784 29.030 29.370 29.336 USD -52,335 32.47 Profit of 5,594 on sale
2024-11-18 SELL -1,005 31.050 31.730 31.662 USD -31,820 32.80 Profit of 1,146 on sale
2024-11-08 SELL -67 34.690 34.710 34.708 USD -2,325 32.60 Loss of -141 on sale
2024-10-21 SELL -67 33.310 34.620 34.489 USD -2,311 0.00 Loss of -2,311 on sale
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-11-10	BUY	67	35.480	33.940	34.094	USD 2,284	31.62
2025-11-06	BUY	68	31.750	30.500	30.625	USD 2,083	31.61
2025-11-04	BUY	68	32.503	31.330	31.447	USD 2,138	31.61
2025-10-30	BUY	340	33.500	32.085	32.226	USD 10,957	31.60
2025-10-29	BUY	136	32.850	33.855	33.754	USD 4,591	31.59
2025-10-22	SELL	-272	32.510	33.770	33.644	USD -9,151	31.55 Loss of -569 on sale
2025-10-20	BUY	136	33.940	33.990	33.985	USD 4,622	31.53
2025-10-17	BUY	339	33.560	34.220	34.154	USD 11,578	31.51
2025-10-15	BUY	536	34.390	34.510	34.498	USD 18,491	31.50
2025-10-03	BUY	455	34.210	35.500	35.371	USD 16,094	31.48
2025-10-02	BUY	65	35.290	37.000	36.829	USD 2,394	31.46
2025-09-30	BUY	130	36.330	36.720	36.681	USD 4,769	31.40
2025-09-26	BUY	130	34.020	35.003	34.905	USD 4,538	31.36
2025-09-25	BUY	130	34.080	34.340	34.314	USD 4,461	31.35
2025-09-18	BUY	68	33.415	34.415	34.315	USD 2,333	31.33
2025-09-17	BUY	204	33.415	34.470	34.365	USD 7,010	31.32
2025-07-17	SELL	-134	36.210	36.360	36.345	USD -4,870	31.21 Loss of -689 on sale
2025-07-11	SELL	-544	35.020	35.280	35.254	USD -19,178	31.10 Loss of -2,261 on sale
2025-07-02	BUY	3,740	32.750	33.950	33.830	USD 126,524	31.02
2025-06-25	BUY	136	32.010	32.350	32.316	USD 4,395	31.00
2025-06-13	BUY	765	34.680	36.010	35.877	USD 27,446	30.93
2025-06-11	BUY	130	35.560	37.100	36.946	USD 4,803	30.86
2025-06-10	BUY	130	35.930	37.560	37.397	USD 4,862	30.82
2025-06-04	SELL	-65	37.700	39.330	39.167	USD -2,546	30.62 Loss of -556 on sale
2025-04-23	BUY	65	29.800	30.850	30.745	USD 1,998	30.45
2025-04-10	SELL	-520	25.820	26.290	26.243	USD -13,646	30.72 Profit of 2,327 on sale
2025-04-08	SELL	-65	24.530	27.670	27.356	USD -1,778	30.84 Profit of 227 on sale
2025-04-07	SELL	-65	26.280	27.195	27.103	USD -1,762	30.90 Profit of 246 on sale
2025-04-04	SELL	-325	27.260	28.555	28.426	USD -9,238	30.94 Profit of 816 on sale
2025-04-01	BUY	272	28.630	29.670	29.566	USD 8,042	30.98
2025-03-31	SELL	-195	29.670	29.840	29.823	USD -5,815	31.00 Profit of 229 on sale
2025-03-21	BUY	884	29.810	30.970	30.854	USD 27,275	31.11
2025-03-14	SELL	-1,008	28.800	29.840	29.736	USD -29,974	31.23 Profit of 1,511 on sale
2025-03-07	SELL	-126	29.800	31.200	31.060	USD -3,914	31.41 Profit of 44 on sale
2025-03-04	SELL	-63	29.250	29.570	29.538	USD -1,861	31.47 Profit of 122 on sale
2025-02-25	BUY	126	29.210	30.960	30.785	USD 3,879	31.64
2025-02-19	SELL	-63	29.770	29.930	29.914	USD -1,885	31.77 Profit of 117 on sale
2025-02-13	BUY	186	29.740	30.050	30.019	USD 5,584	31.95
2025-02-12	BUY	62	29.560	29.785	29.762	USD 1,845	32.00
2025-02-11	BUY	248	28.205	30.120	29.929	USD 7,422	32.07
2024-12-30	SELL	-1,784	29.030	29.370	29.336	USD -52,335	32.47 Profit of 5,594 on sale
2024-11-18	SELL	-1,005	31.050	31.730	31.662	USD -31,820	32.80 Profit of 1,146 on sale
2024-11-08	SELL	-67	34.690	34.710	34.708	USD -2,325	32.60 Loss of -141 on sale
2024-10-21	SELL	-67	33.310	34.620	34.489	USD -2,311	0.00 Loss of -2,311 on sale

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of IMCR

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	15,894	0	38,023	41.8%
2025-09-18	52,118	0	130,116	40.1%
2025-09-17	127,316	106	336,166	37.9%
2025-09-16	22,172	0	60,022	36.9%
2025-09-15	30,923	0	57,072	54.2%
2025-09-12	64,477	10,613	92,753	69.5%
2025-09-11	44,734	7,540	73,113	61.2%
2025-09-10	81,268	14,616	144,419	56.3%
2025-09-09	43,822	0	115,260	38.0%
2025-09-08	57,101	100	123,990	46.1%
2025-09-05	64,334	0	309,443	20.8%
2025-09-04	111,884	0	199,053	56.2%
2025-09-03	182,260	7,100	246,636	73.9%
2025-09-02	45,964	0	82,634	55.6%
2025-08-29	41,259	0	64,534	63.9%
2025-08-28	31,249	0	93,586	33.4%
2025-08-27	33,751	0	76,487	44.1%
2025-08-26	32,058	0	70,614	45.4%
2025-08-25	32,403	0	84,037	38.6%
2025-08-22	52,872	0	149,172	35.4%
2025-08-21	51,854	0	227,606	22.8%
2025-08-20	71,830	3,700	252,162	28.5%
2025-08-19	40,306	0	101,416	39.7%
2025-08-18	23,909	0	80,115	29.8%
2025-08-15	27,295	0	107,899	25.3%
2025-08-14	69,783	0	201,280	34.7%
2025-08-13	51,653	0	170,858	30.2%
2025-08-12	86,991	0	215,476	40.4%
2025-08-11	97,408	0	151,749	64.2%
2025-08-08	90,560	0	201,913	44.9%
2025-08-07	146,985	0	268,466	54.7%
2025-08-06	255,247	482	325,754	78.4%
2025-08-05	27,088	3	57,687	47.0%
2025-08-04	51,053	0	79,772	64.0%
2025-08-01	185,630	0	271,547	68.4%
2025-07-31	59,312	0	115,736	51.2%
2025-07-30	46,707	0	163,165	28.6%
2025-07-29	90,149	50	310,305	29.1%
2025-07-28	30,648	0	78,815	38.9%
2025-07-25	47,095	315	117,716	40.0%
2025-07-24	18,700	18	50,453	37.1%
2025-07-23	67,613	0	306,229	22.1%
2025-07-22	49,560	0	159,351	31.1%
2025-07-21	41,418	0	89,109	46.5%
2025-07-18	42,373	2,608	105,641	40.1%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.

Stock Name / Fund	iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Issuer	Blackrock
ETF Ticker	BTEE(USD) LSE
ETF Ticker	BTEE.L(GBP) LSE